spoT Antibody

Datasheet

Code	CSB-PA572534XA01SZB
Size	Enquire
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Customer Reviews and Q&A
Target Background

Product Details

Full Product Name

Rabbit anti-Shigella flexneri spoT Polyclonal antibody

Uniprot No.

P0AG26

Target Names

spoT

Alternative Names

spoT antibody; SF3690 antibody; S4079 antibody; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase antibody; EC 3.1.7.2 antibody; Penta-phosphate guanosine-3'-pyrophosphohydrolase; antibody; ppGpp)ase antibody

Raised in

Rabbit

Species Reactivity

Shigella flexneri

Immunogen

Recombinant Shigella flexneri spoT protein

Immunogen Species

Shigella flexneri

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Tested Applications

ELISA, WB (ensure identification of antigen)

Protocols

ELISA Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Value-added Deliverables

① 200ug * antigen (positive control);
② 1ml * Pre-immune serum (negative control);

Quality Guarantee

① Antibody purity can be guaranteed above 90% by SDS-PAGE detection;
② ELISA titer can be guaranteed 1: 64,000;
③ WB validation with antigen can be guaranteed positive;

Lead Time

Made-to-order (14-16 weeks)

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function

In eubacteria ppGpp (guanosine 3'-diphosphate 5'-diphosphate) is a mediator of the stringent response that coordinates a variety of cellular activities in response to changes in nutritional abundance. This enzyme catalyzes the degradation of ppGpp into GDP. It may also be capable of catalyzing the synthesis of ppGpp.

Protein Families

RelA/SpoT family

Database Links

KEGG: sfl:SF3690

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

The True Face of Tumor Suppressor Gene p53 EGFR and Its Application in Cancer Therapy An Overview of Cell Death: Necrosis and Apoptosis The Overview of One Category of Important Cell Receptors: Receptor Tyrosine Kinases Cross-reactivity of Antibody: Beneficial or Harmful? CCR8: a Specific Marker on Tregs Cells, the Next Promising Candidate for Antitumor Drugs! Proteolysis Targeting Chimera (PROTAC): A "Revolutionary" Technology in Small Molecule Drug Discovery! ERBB3/HER3: a New Target for Tumor Therapy, a Driver Gene of Multi-Tumors How Do You Get Exosomes? Tag Antibodies, Your Good Partner in Protein Research Homeobox Transcription Factor- NANOG One World, One Hope——What Can We Do about AIDS? Do you Often Trouble in These Problems of ELISA? Monoclonal Antibody Drugs Overview ACE2, The Hottest Target of SARS-CoV-2 Invasion PD-1-- An Important Immune Checkpoint OMA1-A Potential Cancer Therapy Target Analysis of Factors Influencing ELISA Detection Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research? Tumor markers The Oncogene HER2: a New Target for Drug-Resistant Tumors Four Types of ELISA The Overview of Breast Cancer: Related Signaling Pathways, Therapeutic Targets Bispecific Antibody Overview: From Definition to Application The Review of Post-translational Modifications What is Myc Tag: Definition, Function, Applications & Comparison with Other Epitope Tags New Power in the Fight Against Cancer: Spotlight on Rising Stars of ADC Drugs at the 2024 ASCO Annual Meeting CD79A and CD79B: Key Targets in B Cell Signaling Pathways and Therapeutic Potential PVR (CD155): A Key Factor in Tumor Immune Evasion and a Novel Therapeutic Target MSTN: A Key Target for Targeted Therapy in Muscle Diseases DLL4: A Key Target for Angiogenesis Regulation Pioneering CAR-T Cell Therapy: Advancing Personalized Cancer Treatment How Do CTLA-4 Inhibitors Work? A Complete Guide for Early-Career Researchers Interleukin-2 (IL2): The "Double-Edged Sword" of the Immune System Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：